Home›Stock Screener›Kopran›Quarterly Results

Kopran Quarterly Results for Trading Insights

Latest Quarter Net Profit
₹19 Cr
QMar 2026
Quarterly Results

In Mar 2026, Kopran (KOPRAN) reported revenue ₹234 Cr and net profit ₹19 Cr — revenue +33.0% YoY. Analyse Kopran shareholding analysis to track promoter, FII and institutional holdings.

KOPRAN Quarterly Results — Revenue, Profit & EPS Highlights

Kopran latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. For annual financials, live price and key ratios, visit KOPRAN screener.

  • Revenue of ₹234 Cr in Mar 2026 (+50.0% vs Jun 2026, +33.0% vs Mar 2025)
  • Net Profit of ₹19 Cr in Mar 2026 (+171.4% vs Jun 2026, +90.0% vs Mar 2025)
  • EBITDA of ₹33 Cr in Mar 2026 (+83.3% vs Jun 2026)
  • Operating Margin of 14.0% in Mar 2026 (+4.0pp vs Jun 2026)
  • Earnings Per Share of ₹3.91 in Mar 2026 (+181.3% vs Jun 2026)

Kopran Quarterly Results — Revenue, EBITDA, Net Profit & EPS

KOPRAN quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Mar 2026 Jun 2026 Sept 2025 Mar 2025 Jun 2025 QoQ YoY
Revenue (₹ Cr) 234 156 118 176 138 50.0% 33.0%
Net Profit (₹ Cr) 19 7 -10 10 7 - -
EBITDA (₹ Cr) 33 18 -5 20 17 - -
EPS (₹) 3.91 1.39 -2.06 2.00 1.54 - -
Operating Margin (%) 14.0% 10.0% -4.0% 10.0% 10.0% - -

KOPRAN Share Price Trend — 1-Year Movement Across Quarterly Results

Kopran 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. View KOPRAN 52-week chart for the annual high/low range and current price position.

Profitability Ratios

Profit Margin 8.1%
EBITDA Margin 14.1%
Operating Margin 14.0%
ROE (Annual) 14.3%

Balance Sheet Highlights

Total Assets ₹908 Cr
Total Equity ₹530 Cr
Current Assets ₹523 Cr
Current Liabilities ₹32 Cr

Cash Flow Analysis

Operating Cash Flow ₹67 Cr
Investing Cash Flow ₹-65 Cr
Financing Cash Flow ₹-21 Cr
Net Cash Flow ₹-19 Cr

Current Market Data

Current Price ₹277.60
Exchange NSE
Last Updated Sep 18, 2026

Revenue Trend (₹ Cr)

Mar 2025 176
Sept 2025 118
Jun 2026 156
Mar 2026 234

Net Profit Trend (₹ Cr)

Mar 2025 10
Sept 2025 -10
Jun 2026 7
Mar 2026 19

Operating Margin Trend (%)

Mar 2025 10.0%
Sept 2025 -4.0%
Jun 2026 10.0%
Mar 2026 14.0%

KOPRAN vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Kopran latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Mar 2026 		₹441,477.63 Cr 1837.3 15,018 2,710 -5.6% - 18.0% 162.6
Divis Laboratories
Mar 2026 		₹247,469.81 Cr 9375.0 2,986 751 -5.0% - 25.2% 331.2
Torrent Pharmaceuti…
Mar 2026 		₹188,719.51 Cr 4840.0 4,111 364 +27.7% +42.2% 8.9% 420.5
Cipla
Mar 2026 		₹112,654.03 Cr 1394.5 6,612 543 -9.3% - 8.2% 203.0
Zydus Life Science
Mar 2026 		₹112,607.65 Cr 1160.0 7,569 1,341 -4.3% - 17.7% 91.7
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores